BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1342984)

  • 1. [Autotransplantation in lymphomas: is it effective?].
    Surbone A; Armitage JO; Gale RP
    Gematol Transfuziol; 1992; 37(7-8):3-6. PubMed ID: 1342984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autotransplants in advanced non-Hodgkin lymphoma: are they effective?
    Surbone A; Armitage JO; Gale RP
    Cell Transplant; 1992; 1(5):343-7. PubMed ID: 1344306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma.
    Gale RP; Park RE; Dubois R; Bierman PJ; Fisher RI; Loh KK; Peterson BA; Phillips GL; Portlock CS; Rosenblum D; Armitage JO
    Leuk Lymphoma; 1998 Dec; 32(1-2):139-49. PubMed ID: 10037009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autotransplants in leukaemia.
    Gale RP; Butturini A
    Lancet; 1989 Aug; 2(8658):315-7. PubMed ID: 2569112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.
    Champlin R; Gale RP
    Semin Hematol; 1987 Jan; 24(1):55-67. PubMed ID: 3547673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.
    Philip T; Armitage JO; Spitzer G; Chauvin F; Jagannath S; Cahn JY; Colombat P; Goldstone AH; Gorin NC; Flesh M
    N Engl J Med; 1987 Jun; 316(24):1493-8. PubMed ID: 3295541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer.
    Gale RP; Park RE; Dubois R; Bitran JD; Buzdar A; Hortobagyi G; Jones SE; Lazar GS; Spitzer G; Swain SM; Vaughn CB; Vogel CE; Martino S
    Clin Transplant; 2000 Feb; 14(1):32-41. PubMed ID: 10693633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotransplants: now and in the future.
    Gale RP; Armitage JO; Dicke KA
    Bone Marrow Transplant; 1991 Feb; 7(2):153-7. PubMed ID: 2049559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
    Haioun C; Lepage E; Gisselbrecht C; Coiffier B; Bosly A; Tilly H; Morel P; Nouvel C; Herbrecht R; D'Agay MF
    J Clin Oncol; 1994 Dec; 12(12):2543-51. PubMed ID: 7527453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
    Vose JM; Zhang MJ; Rowlings PA; Lazarus HM; Bolwell BJ; Freytes CO; Pavlovsky S; Keating A; Yanes B; van Besien K; Armitage JO; Horowitz MM;
    J Clin Oncol; 2001 Jan; 19(2):406-13. PubMed ID: 11208832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
    Jost LM; Jacky E; Dommann-Scherrer C; Honegger HP; Maurer R; Sauter C; Stahel RA
    Ann Oncol; 1995 May; 6(5):445-51. PubMed ID: 7545428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.
    Haioun C; Lepage E; Gisselbrecht C; Bastion Y; Coiffier B; Brice P; Bosly A; Dupriez B; Nouvel C; Tilly H; Lederlin P; Biron P; Brière J; Gaulard P; Reyes F
    J Clin Oncol; 1997 Mar; 15(3):1131-7. PubMed ID: 9060555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
    Lazarus HM; Rowlings PA; Zhang MJ; Vose JM; Armitage JO; Bierman PJ; Gajewski JL; Gale RP; Keating A; Klein JP; Miller CB; Phillips GL; Reece DE; Sobocinski KA; van Besien K; Horowitz MM
    J Clin Oncol; 1999 Feb; 17(2):534-45. PubMed ID: 10080597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.
    Lazzarino M; Arcaini L; Bernasconi P; Alessandrino EP; Gargantini L; Cairoli R; Orlandi E; Astori C; Brusamolino E; Pagnucco G; Colombo AA; Calatroni S; Iacona I; Regazzi MB; Morra E
    Br J Haematol; 2002 Jan; 116(1):229-35. PubMed ID: 11841421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.
    Verdonck LF; van Putten WL; Hagenbeek A; Schouten HC; Sonneveld P; van Imhoff GW; Kluin-Nelemans HC; Raemaekers JM; van Oers RH; Haak HL
    N Engl J Med; 1995 Apr; 332(16):1045-51. PubMed ID: 7898521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission.
    Gale RP; Park RE; Dubois RW; Herzig GP; Hocking WG; Horowitz MM; Keating A; Kempin S; Linker CA; Schiffer CA; Wiernik PH; Weisdorf DJ; Rai KR
    Leuk Res; 1998 Nov; 22(11):973-81. PubMed ID: 9783798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-Hodgkin's malignant lymphoma. Therapeutic value of autologous bone marrow transplantation].
    Gorin NC; Najman A; Douay L; Salmon C; David R; Stachowiak J; Parlier Y; Oppenheimer M; Lecomte D; Lopez M
    Presse Med; 1983 Sep; 12(31):1917-23. PubMed ID: 6226002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.
    Wheeler C; Strawderman M; Ayash L; Churchill WH; Bierer BE; Elias A; Gilliland DG; Antman K; Guinan EC; Eder JP
    J Clin Oncol; 1993 Jun; 11(6):1085-91. PubMed ID: 8099120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma.
    Chen CI; Crump M; Tsang R; Stewart AK; Keating A
    Br J Haematol; 2001 Apr; 113(1):202-8. PubMed ID: 11328303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.